Ulrich Karl Walter Spengler
Directeur Général chez altona Diagnostics GmbH
Profil
Ulrich Karl Walter Spengler is the Co-Managing Director and founder of altona Diagnostics GmbH since 1998.
He is also the founder of Artus GmbH.
Personaldienst.
Currently, he is the Co-Chief Executive Officer of altona Diagnostics Holding GmbH, Director of 2cureX ApS, Director of LISCO Beteiligungs - Und Beratungsgesellschaft mbH, and Director of Altona Diagnostics UK Ltd.
He previously served as Director of 2cureX AB from 2017 to 2019.
Postes actifs de Ulrich Karl Walter Spengler
Sociétés | Poste | Début |
---|---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Directeur/Membre du Conseil | 01/01/2013 |
LISCO Beteiligungs - Und Beratungsgesellschaft mbH | Directeur/Membre du Conseil | - |
altona Diagnostics GmbH
altona Diagnostics GmbH Medical SpecialtiesHealth Technology Altona Diagnostics GmbH develops and commercializes polymerase chain reaction based assays and molecular diagnostic test solutions in the field of infectious diseases. The private company is based in Hamburg, DE. and has subsidiaries in United Kingdom. The German company was founded in 1998 by Ulrich Karl Walter Spengler. Ulrich Karl Walter Spengler has been the CEO since 1998. | Directeur Général | 01/01/1998 |
Altona Diagnostics UK Ltd.
Altona Diagnostics UK Ltd. Medical SpecialtiesHealth Technology Part of Altona Diagnostics GmbH, Altona Diagnostics UK Ltd. is a medical diagnostics company based in Liverpool, UK. The British company's product lines include Altostar®, Flexstar®, and Realstar®, which cater to individual lab requirements. Altona Diagnostics also provides SARS-CoV-2 real-time PCR test kits, including current reactivity analyses in response to mutations, and two RealStar® PCR malaria kits to help combat malaria. Founded in 2017, the company develops and manufactures in vitro diagnostic tests for the PCR-based detection of pathogens such as viruses, bacteria, or parasites. | Directeur/Membre du Conseil | 27/02/2017 |
Anciens postes connus de Ulrich Karl Walter Spengler
Sociétés | Poste | Fin |
---|---|---|
2CUREX AB | Directeur/Membre du Conseil | 02/04/2019 |
Artus GmbH Personaldienst | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
2CUREX AB | Health Technology |
Entreprise privées | 5 |
---|---|
2cureX ApS
2cureX ApS Pharmaceuticals: MajorHealth Technology 2cureX ApS develops and manufactures drugs and technology for the treatment of cancer. Its ChemoCellomics, integrates synthesis of compound libraries with throughput screening (HTS) in primary cells from patients. The company was founded by Ole Thastrup, Timm Jessen, and Grith Hagel in 2006 and is headquartered in Birkerod, Denmark. | Health Technology |
LISCO Beteiligungs - Und Beratungsgesellschaft mbH | |
altona Diagnostics GmbH
altona Diagnostics GmbH Medical SpecialtiesHealth Technology Altona Diagnostics GmbH develops and commercializes polymerase chain reaction based assays and molecular diagnostic test solutions in the field of infectious diseases. The private company is based in Hamburg, DE. and has subsidiaries in United Kingdom. The German company was founded in 1998 by Ulrich Karl Walter Spengler. Ulrich Karl Walter Spengler has been the CEO since 1998. | Health Technology |
Artus GmbH Personaldienst | Commercial Services |
Altona Diagnostics UK Ltd.
Altona Diagnostics UK Ltd. Medical SpecialtiesHealth Technology Part of Altona Diagnostics GmbH, Altona Diagnostics UK Ltd. is a medical diagnostics company based in Liverpool, UK. The British company's product lines include Altostar®, Flexstar®, and Realstar®, which cater to individual lab requirements. Altona Diagnostics also provides SARS-CoV-2 real-time PCR test kits, including current reactivity analyses in response to mutations, and two RealStar® PCR malaria kits to help combat malaria. Founded in 2017, the company develops and manufactures in vitro diagnostic tests for the PCR-based detection of pathogens such as viruses, bacteria, or parasites. | Health Technology |